Notizia - Recent Pharma, Healthcare and Biotech Happenings

Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 Million Hologic, a global champion of women's health based in Massachusetts, United States, is taking possession of Focal Therapeutics, a medical device company, for USD 125 million to complement its breast-conserving surgery permit. This leads to Focal’s BioZorb implantable used in lumpectomies to designate tumour removal sites for monitoring and future treatments. The device’s titanium marker clips work with existing screening and imaging methods to help improve outcomes over the long term and it is placed during the tissue removal procedure with a range of sizes. Allogene zeroed in...